Kronos Bio Inc (KRON)
1.02
-0.01
(-0.97%)
USD |
NASDAQ |
May 03, 16:00
1.01
-0.01
(-0.98%)
After-Hours: 20:00
Kronos Bio 1 Year Total Returns (Daily): -39.29% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -39.29% |
May 02, 2024 | -36.02% |
May 01, 2024 | -36.81% |
April 30, 2024 | -37.58% |
April 29, 2024 | -39.39% |
April 26, 2024 | -25.09% |
April 25, 2024 | -26.32% |
April 24, 2024 | -26.15% |
April 23, 2024 | -29.10% |
April 22, 2024 | -28.36% |
April 19, 2024 | -19.84% |
April 18, 2024 | -21.67% |
April 17, 2024 | -23.53% |
April 16, 2024 | -16.15% |
April 15, 2024 | -12.31% |
April 12, 2024 | -8.87% |
April 11, 2024 | -12.40% |
April 10, 2024 | -13.18% |
April 09, 2024 | -16.91% |
April 08, 2024 | -11.76% |
April 05, 2024 | -6.82% |
April 04, 2024 | -13.67% |
April 03, 2024 | -12.50% |
April 02, 2024 | -13.01% |
April 01, 2024 | -5.48% |
Date | Value |
---|---|
March 28, 2024 | -8.45% |
March 27, 2024 | -12.68% |
March 26, 2024 | -11.85% |
March 25, 2024 | -8.89% |
March 22, 2024 | -5.22% |
March 21, 2024 | -18.64% |
March 20, 2024 | -18.79% |
March 19, 2024 | -23.18% |
March 18, 2024 | -23.84% |
March 15, 2024 | -22.67% |
March 14, 2024 | -28.30% |
March 13, 2024 | -28.09% |
March 12, 2024 | -23.99% |
March 11, 2024 | -16.22% |
March 08, 2024 | -22.29% |
March 07, 2024 | -25.00% |
March 06, 2024 | -32.20% |
March 05, 2024 | -42.70% |
March 04, 2024 | -40.45% |
March 01, 2024 | -41.04% |
February 29, 2024 | -40.23% |
February 28, 2024 | -29.31% |
February 27, 2024 | -28.65% |
February 26, 2024 | -31.74% |
February 23, 2024 | -38.15% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.46%
Minimum
Dec 22 2022
-5.22%
Maximum
Mar 22 2024
-64.23%
Average
-69.70%
Median
Feb 02 2023
1 Year Total Returns (Daily) Benchmarks
CEL-SCI Corp | -27.23% |
AIM ImmunoTech Inc | -15.65% |
IGC Pharma Inc | 53.98% |
NovaBay Pharmaceuticals Inc | -90.79% |
Protalix BioTherapeutics Inc | -63.81% |